| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/07/1993 | EP0535336A2 MK protein as cell growth inhibitor |
| 04/07/1993 | EP0535241A1 Novel leucine aminopeptidase |
| 04/07/1993 | EP0535155A1 Libraries of modified peptides with protease resistance |
| 04/07/1993 | EP0535148A1 Stimulation of bone marrow stromal and progenitor cells |
| 04/07/1993 | EP0535092A1 Protease nexin-i variants |
| 04/07/1993 | EP0535088A1 Chimeric toxins with improved inter-domain geometry |
| 04/07/1993 | EP0535084A1 Improved ascites production of monoclonal antibodies using an immunosuppressive anti-cd4-related antibody |
| 04/07/1993 | EP0535060A1 Antifungal polypeptide, process for producing it. |
| 04/07/1993 | EP0535038A1 Mammalian adipogenic factors |
| 04/07/1993 | EP0535037A1 Hybrid plasminogen activators |
| 04/07/1993 | EP0535032A1 Therapy and prophylaxis of autoimmune diseases |
| 04/07/1993 | EP0534988A1 Inhibitors of factor xii activation and applications thereof |
| 04/07/1993 | EP0534978A1 Interleukin-1 antagonist and uses thereof |
| 04/07/1993 | EP0491849A4 A method for the purification of transforming growth factor (tgf-) |
| 04/07/1993 | EP0366728B1 Polypeptides with fibronectin activity |
| 04/07/1993 | EP0215110B1 Production of human somatomedin c |
| 04/06/1993 | US5200509 Human somatomedin carrier protein subunits and process for producing them; recombinant DNA molecules, hosts, processes and human somatomedin carrier protein-like polypeptides |
| 04/06/1993 | US5200508 Cell surface antigen that binds with L6 monoclonal antibody |
| 04/06/1993 | US5200505 R106 compounds |
| 04/06/1993 | US5200426 Preventing the growth or differentiation of common acute lymphoblastic leukemia antigen and human leukemia cells |
| 04/06/1993 | US5200406 Nootropic agents; learning enhancement |
| 04/06/1993 | US5200397 Administering an oligopeptides anticoagulants or wound healing agents |
| 04/06/1993 | US5200396 Method of treating neurodegenerative disorders using epidermal growth factor |
| 04/06/1993 | US5200395 Pharmaceutical composition of BUF-5 for treating anemia |
| 04/06/1993 | US5200394 Derivatives of type a and b synergimycins |
| 04/06/1993 | US5200393 A lipid excipient of mono-oleoyl phosphatidylethanolamine (a lysophospholipid), a salt solution and a water soluble protein e.g. insulin |
| 04/06/1993 | US5200339 Brain-derived, calcium-activated proteolytic factor comprising a serine protease; Alzheimer's disease |
| 04/06/1993 | US5200184 Deacylation using hydrolase enzyme |
| 04/06/1993 | US5200183 Recombinant bile salt activated lipases |
| 04/06/1993 | US5200182 Antiviral or antibacterial composition and method of use |
| 04/06/1993 | US5200181 Treating jaundice patients by administering a immobilized enzyme conjugated to inert polymeric particle carrier |
| 04/06/1993 | US5200177 Treatment of atopic disorders with gamma-interferon |
| 04/06/1993 | US5200176 Method for protection of ischemic tissues using tumor nerosis factor |
| 04/06/1993 | US5199942 Method for improving autologous transplantation |
| 04/06/1993 | CA1315791C Oxathiolanes |
| 04/06/1993 | CA1315716C Monoclonal antibodies to the light chain region of human factor xii and methods of preparing and using the same |
| 04/06/1993 | CA1315688C Compositions and methods for improving cold tolerance in animals and humans |
| 04/06/1993 | CA1315678C Alpha-tocopherol based vesicles |
| 04/06/1993 | CA1315677C Use of epidermal growth factor |
| 04/06/1993 | CA1315675C Lactoferrin as a dietary ingredient promoting the growth of the gastointestinal tract |
| 04/02/1993 | CA2079541A1 Injectable extended release formulations and methods |
| 04/01/1993 | WO1993006233A1 Tumor immunotherapy utilizing a method of overcoming the resistance of a progressively growing tumor |
| 04/01/1993 | WO1993006232A1 HUMAN MONOCLONAL ANTIBODY AGAINST GLYCOPROTEIN IIb/IIIa |
| 04/01/1993 | WO1993006231A1 Anti-human milk fat globule humanised antibodies |
| 04/01/1993 | WO1993006230A1 Annexin xi |
| 04/01/1993 | WO1993006229A1 CLONING OF cDNA ENCODING A FUNCTIONAL HUMAN INTERLEUKIN-8 RECEPTOR |
| 04/01/1993 | WO1993006228A1 A new form of liposaccharide binding protein (lbp) |
| 04/01/1993 | WO1993006218A2 Chimeras of parainfluenza virus type 3 proteins f and hn as vaccines |
| 04/01/1993 | WO1993006216A1 Fusion proteins targeted to lysosomes, for the treatment of aids |
| 04/01/1993 | WO1993006213A1 Production of chimeric antibodies - a combinatorial approach |
| 04/01/1993 | WO1993006211A1 Vaccine for mystery swine disease and method for diagnosis thereof |
| 04/01/1993 | WO1993006135A1 Diagnosing and treating autoimmune disorders |
| 04/01/1993 | WO1993006134A1 Factors for the cellular functional regulation and biological applications thereof |
| 04/01/1993 | WO1993006131A1 Porcine adipocyte antigens and their use in the immunological control of fat |
| 04/01/1993 | WO1993006129A1 Polypeptide inhibitor of the replication of hsu and similar viruses |
| 04/01/1993 | WO1993006128A1 Tnf antagonist peptides |
| 04/01/1993 | WO1993006127A1 Novel amino acid prodrug renin inhibitors |
| 04/01/1993 | WO1993006126A1 Immunoreactive hepatitis c virus polypeptide compositions |
| 04/01/1993 | WO1993006123A1 Human cyclin e |
| 04/01/1993 | WO1993006122A1 Duplex-forming, polynucleotide conjugates |
| 04/01/1993 | WO1993006117A1 Sf-25 antibodies, especially chimeric antibodies, with specificity for the human tumor sf-25 antigen, methods for their production, and uses thereof |
| 04/01/1993 | WO1993006116A1 Glial derived neurotrophic factor |
| 04/01/1993 | WO1993005823A1 Bone-growth-stimulating composition |
| 04/01/1993 | WO1993005822A1 Tissue glue prepared by using cryoprecipitate |
| 04/01/1993 | WO1993005814A1 Competitive inhibition of t cell-b cell interactions |
| 04/01/1993 | WO1993005809A1 Pharmaceutical compositions comprising natriuretic peptides or neutral endopeptidase inhibitors for treating or preventing myointimal proliferation |
| 04/01/1993 | WO1993005808A1 Bone-growth-stimulating composition |
| 04/01/1993 | WO1993005807A2 Erythropoietin potentiating agents and methods for their use |
| 04/01/1993 | WO1993005806A1 Composition and method of treating hepatitis c |
| 04/01/1993 | WO1993005805A1 Emulsion containing parathyroid hormone for pernasal administration |
| 04/01/1993 | WO1993005804A1 Activated stromal fibroblast-specific antibody, f19 and methods of using the same |
| 04/01/1993 | WO1993005803A1 Anti-inflammatory selectin inhibitors |
| 04/01/1993 | WO1993005802A1 Biologically active amphiphilic peptide compositions and uses therefor |
| 04/01/1993 | WO1993005801A1 Use of il-5 to treat solid tumors |
| 04/01/1993 | WO1993005800A1 Method and compositions for the treatment of cerebral palsy |
| 04/01/1993 | WO1993005799A1 Lyophilized stable pharmaceutical compositions containing a granulocyte macrophage colony stimulating factor |
| 04/01/1993 | WO1993005797A1 Compositions comprising a bactericidal/permeability increasing protein and a lipid carrier, methods of making same, and uses thereof |
| 04/01/1993 | WO1993005796A1 Method for producing human antibodies in a non-human animal, and animals therefor |
| 04/01/1993 | WO1993005793A1 A novel conjugate, its preparation and use and a substrate prepared with the conjugate |
| 04/01/1993 | WO1993005786A1 Novel gabaa receptor with steroid binding sites |
| 04/01/1993 | WO1993005783A1 Diagnosis and therapy for parkinson's disease |
| 04/01/1993 | WO1993005780A1 Amino acids containing parenteral formulations for the treatment of hypotension and related pathologies |
| 04/01/1993 | WO1993005774A1 Complexes of anthracycline antibiotics with polyunsaturated fatty acids in lipid emulsions |
| 04/01/1993 | WO1993005765A1 Pressurised aerosol compositions |
| 04/01/1993 | WO1993005752A1 Cosmetic and dermatological preparations |
| 04/01/1993 | WO1993005751A2 Osteogenic proteins in the treatment of bone deseases |
| 04/01/1993 | WO1993005658A1 Targeted cytotoxic effector cells and methods for their production and use |
| 04/01/1993 | WO1993003755A3 Use of relaxin in cardiovascular therapy and in the treatment of neurodegenerative diseases |
| 04/01/1993 | WO1993003148A3 Tau/neurofilament protein kinases pk40 and pk36 |
| 04/01/1993 | WO1993001286A3 Localized oligonucleotide therapy |
| 04/01/1993 | WO1992022583A3 Tri- and tetra-valent monospecific antigen-binding proteins |
| 04/01/1993 | WO1992018610A3 Compositions and methods for endothelial binding |
| 04/01/1993 | DE4131940A1 Kosmetische und dermatologische zubereitungen Cosmetic and dermatological preparations |
| 04/01/1993 | CA2119927A1 Duplex-forming polynucleotide conjugates |
| 04/01/1993 | CA2119019A1 Pharmaceutical compositions comprising natriuretic peptides or neutral endopeptidase inhibitors for treating or preventing myointimal proliferation |
| 04/01/1993 | CA2119003A1 Factors for the cellular functional regulation and biological applications thereof |
| 04/01/1993 | CA2118939A1 Biologically active amphiphilic peptide compositions and uses thereof |
| 04/01/1993 | CA2118938A1 Novel gabaa receptor with steroid binding sites |
| 04/01/1993 | CA2116684A1 Amino acids containing parenteral formulations for the treatment of hypotension and related pathologies |
| 04/01/1993 | CA2116227A1 Annexin xi |